StockNews.AI
MDT
StockNews.AI
111 days

Smart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RF

1. Growth in gastrointestinal disorders boosts demand for smart pills. 2. Smart pills improve non-invasive diagnostics and treatment efficiency. 3. North America leads smart pills market with significant growth forecast. 4. Technological advancements in AI and IoT enhance smart pill capabilities. 5. Increased healthcare spending supports smart pill adoption and market expansion.

7m saved
Insight
Article

FAQ

Why Bullish?

The growing market for smart pills positively influences Medtronic's opportunity in diagnostics.

How important is it?

The shift to smart pills aligns with Medtronic's innovation strategy and market focus.

Why Long Term?

As the aging population increases, demand for smart pills will persist in the long term.

Related Companies

MDTISRGTechnological advancementsGIBTMO
The rising prevalence of gastrointestinal disorders and the increasing demand for non-invasive diagnostic solutions are major factors fueling this growth. As the healthcare industry shifts toward minimally invasive technologies, smart pills are revolutionizing diagnostics and treatment approaches. These ingestible medical devices, equipped with sensors, microchips, and wireless communication capabilities, enable real-time patient monitoring, precise drug delivery, and enhanced disease tracking. The growing need for personalized medicine and remote healthcare solutions is further accelerating market adoption, as smart pills offer a seamless blend of diagnostics and treatment with minimal discomfort to patients.Additionally, the rising burden of chronic diseases, an aging global population, and increased healthcare spending are contributing to the market's expansion. Government initiatives supporting digital healthcare and technological advancements in artificial intelligence (AI) and the Internet of Things (IoT) are reinforcing the market's rapid evolution. AI-powered smart pills are enhancing data processing efficiency, enabling faster and more accurate diagnoses while optimizing treatment plans. Meanwhile, IoT integration allows continuous patient monitoring, reducing hospital visits and improving overall healthcare management. With healthcare providers and patients increasingly recognizing the benefits of smart pills, the market is poised for exponential growth over the next decade.The market is segmented based on components into products and patient monitoring software. In 2024, the product segment generated USD 725.9 million, largely driven by the increasing adoption of smart capsules embedded with microchips and sensors. These capsules play a crucial role in monitoring gastrointestinal health, ensuring medication adherence, and tracking disease progression. By delivering real-time data, smart capsules enable precise drug administration while eliminating the need for traditional invasive diagnostic procedures. The ease of use and non-invasive nature of these solutions are making them a preferred choice for medical diagnostics and therapeutic applications.The market is further classified by target area, with applications spanning the stomach, small intestine, large intestine, and esophagus. The stomach segment accounted for 44.1% of the market share in 2024, largely due to the increasing prevalence of stomach-related disorders and the demand for real-time, non-invasive diagnostic tools. Smart pills designed for stomach applications offer enhanced diagnostic accuracy and improved treatment efficacy, addressing a broad range of gastrointestinal conditions. The growing incidence of gastric diseases is fueling demand for these innovative solutions, making the stomach a dominant segment within the market.North America remains a leading market for smart pills, reaching USD 455.5 million in 2024 and expected to grow at a CAGR of 11.3% in the coming years. The region benefits from a well-established healthcare infrastructure, early adoption of advanced medical technologies, and a rising elderly population prone to chronic illnesses. The increasing number of gastrointestinal disorders, coupled with continuous technological advancements in ingestible sensors, is driving market expansion. Key industry players focused on research and innovation in medical technology are further propelling market growth, reinforcing North America's stronghold in the global smart pills industry.Comprehensive Market Analysis and Forecast Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscapeCompetitive landscape with Porter's Five Forces and PESTEL analysisMarket size, segmentation, and regional forecastsIn-depth company profiles, business strategies, financial insights, and SWOT analysis Key Topics Covered:Chapter 1 Methodology and ScopeChapter 2 Executive Summary2.1 Industry 360 synopsisChapter 3 Industry Insights3.1 Industry ecosystem analysis3.2 Industry impact forces3.2.1 Growth drivers3.2.1.1 Increasing prevalence of gastrointestinal disorders3.2.1.2 Continuous improvements in smart pill technology3.2.1.3 Growing demand for non-invasive diagnostic tools3.2.2 Industry pitfalls and challenges3.2.2.1 Stringent regulatory requirements3.2.2.2 High cost of devices3.3 Growth potential analysis3.4 Technology landscape3.5 Regulatory landscape3.6 Future market trends3.7 Porter's analysis3.8 PESTEL analysisChapter 4 Competitive Landscape, 20244.1 Introduction4.2 Company matrix analysis4.3 Competitive analysis of major market players4.4 Competitive positioning matrix4.5 Strategy dashboardChapter 5 Market Estimates and Forecast, by Component, 2021-2034 ($ Mn)5.1 Key trends5.2 Product5.2.1 Capsule5.2.2 Other products5.3 Patient monitoring softwareChapter 6 Market Estimates and Forecast, by Target Area, 2021-2034 ($ Mn)6.1 Key trends6.2 Stomach6.3 Small intestine6.4 Large intestine6.5 EsophagusChapter 7 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)7.1 Key trends7.2 Capsule endoscopy7.3 Targeted drug delivery7.4 Vital sign monitoringChapter 8 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)8.1 Key trends8.2 Hospitals8.3 Diagnostic centers8.4 Other end useChapter 9 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)Chapter 10 Company Profiles ANX RoboticaBodycapCapsoVisionCheck-CapetectRxIntromedicMedtronicOtsuka HoldingsOlympus CorporationRF Co For more information about this report visit https://www.researchandmarkets.com/r/aidps8 About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Related News